🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › Tennessee › Memphis

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Memphis, TN keessatti

Qorannoo 7 Leukemia Biphenotypicii Hamaa f Memphis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Namoota walitti qabaa jiraSadarkaa 2
  • St. Jude Children's Research Hospital, Memphis
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06390319

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • St. Jude Children's Research Hospital, Memphis
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Namoota walitti qabaa jiraSadarkaa 4
  • St. Jude Children's Research Hospital, Memphis
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06289673

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Baptist Clinical Research Institute, Memphis
Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • St. Jude Children's Research Hospital, Memphis
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Leukemia Biphenotypicii Hamaa magaalota biroo keessatti

Qorannoo biroo Memphis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.